You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / CE

The Atopic Dermatitis Patient: A Virtual Patient Encounter

  • Authors: Melinda J. Gooderham, MSc, MD, FRCPC; Brett King, MD, PhD
  • CME / CE Released: 3/4/2022
  • Valid for credit through: 3/4/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

    Nurses - 1.00 ANCC Contact Hour(s) (1 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for a global audience of dermatologists, allergists and clinical immunologists, physician assistants, and other healthcare providers who treat patients with atopic dermatitis (AD).

The goal of this curriculum is to improve the recognition of the burden of AD and the identification of patients who are candidates for treatment with targeted systemic agents. Additionally, the education aims to improve knowledge of new and emerging systemic therapies for AD, their role in treatment, and the mechanisms of these therapies in the context of AD pathology.

Upon completion of this activity, participants will:

  • Demonstrate improved performance associated with
    • Assessing appropriateness of systemic AD therapy based on disease-related factors
    • Modifying AD treatment based on response to prior/current therapies
    • Selecting evidence-based treatments that consider AD symptoms


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • Melinda J. Gooderham, MSc, MD, FRCPC

    Assistant Professor
    Queen’s University
    Dermatologist and Medical Director
    SKiN Center for Dermatology
    Peterborough, Ontario, Canada

    Disclosures

    Disclosure: Melinda J. Gooderham, MSc, MD, FRCPC, has disclosed the following relevant financial relationships:
    Grants for clinical research from: AbbVie; Akros; Amgen; Arcutis; Bausch Health; Boehringer Ingelheim; Bristol Myers Squibb; Coherus; Dermavant; Dermira; Eli Lilly; Galderma; GlaxoSmithKline; Janssen; Kyowa Kirin; LEO Pharma; Novartis; Pfizer; Sanofi Genzyme; Sienna; Sun Pharma; UCB
    Advisor or consultant for: AbbVie; Akros; Amgen; Arcutis; Bausch Health; Boehringer Ingelheim; Bristol Myers Squibb; Dermavant; Eli Lilly; Galderma; Janssen; Kyowa Kirin; LEO Pharma; Novartis; Pfizer; Sanofi Genzyme; Sun Pharma; UCB
    Speaker or member of speakers bureau for: AbbVie; Amgen; Arcutis; Bausch Health; Boehringer Ingelheim; Bristol Myers Squibb; Eli Lilly; Galderma; Janssen; LEO Pharma; Novartis; Pfizer; Regeneron; Sanofi Genzyme; Sun Pharma; UCB

  • Brett King, MD, PhD

    Associate Professor of Dermatology
    Yale School of Medicine
    New Haven, Connecticut, United States

    Disclosures

    Disclosure: Brett King, MD, PhD, has disclosed the following relevant financial relationships:
    Advisor or consultant for: AbbVie; Aclaris Therapeutics Inc; AltruBio Inc; Almirall; AnaptysBio; Arena Pharmaceuticals; Bioniz Therapeutics; Bristol Myers Squibb; Concert Pharmaceuticals Inc; Dermavant Sciences Inc; Horizon Therapeutics; Eli Lilly; Incyte Corp; LEO Pharma; Otsuka/Visterra Inc; Pfizer; Regeneron; Sanofi Genzyme; TWi Biotechnology Inc; Viela Bio
    Speaker or member of speakers bureau for: Pfizer; Regeneron; Sanofi Genzyme

Editors

  • Briana Betz, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Briana Betz, PhD, has disclosed no relevant financial relationships.

  • Terra Sumstine

    Medical Writer, Chichester Associates Inc.

    Disclosures

    Disclosure: Terra Sumstine has disclosed no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC 

    Disclosures

    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships. 

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 1.0 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

The Atopic Dermatitis Patient: A Virtual Patient Encounter

Authors: Melinda J. Gooderham, MSc, MD, FRCPC; Brett King, MD, PhDFaculty and Disclosures

CME / CE Released: 3/4/2022

Valid for credit through: 3/4/2023

processing....

ABOUT THIS ACTIVITY
Explore how updated treatment options can improve quality of life for patients with atopic dermatitis.

Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface.

Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.

patient simulation